SCHEMBL13428282

SCHEMBL13428282

c1ccc(-c2c3ccc(-n4c5ccccc5c5ccccc54)cc3c(-c3ccccc3)c3cc(-n4c5ccccc5c5ccccc54)ccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ATM Q13315 1/20 0.53
KMT2A Q03164 3/20 0.44
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
IL1R1 P14778 1/20 0.37
HDAC4 P56524 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
ACHE P22303 1/20 0.35
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925373 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL12928330 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL11910842 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13319694 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13427964 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13777107 0.95 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL26935353 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13615689 0.93 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13319722 0.92 L3MBTL1 (0.48) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13777108 0.92 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A L3MBTL1 1117/4885KDM4E 4138/4885ATM 4252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.